ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

BIOR Biora Therapeutics Inc

0.7003
-0.037 (-5.02%)
18 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Biora Therapeutics Inc BIOR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.037 -5.02% 0.7003 09:00:00
개장가 저가 고가 종가 전일 종가
0.74 0.7001 0.75 0.7297 0.7373
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/05/202405:05GLOBEBiora Therapeutics Provides Corporate Update..
07/05/202421:00GLOBEBiora Therapeutics to Report First Quarter 2024 Financial..
06/05/202421:00GLOBEBiora Therapeutics to Present Clinical Data on Device..
30/04/202421:00GLOBEBiora Therapeutics Announces Completion of..
08/04/202421:00GLOBEBiora Therapeutics Announces New Patent Covering its BioJet™..
04/04/202421:00GLOBEBiora Therapeutics Achieves Positive Interim Results for..
04/04/202405:05GLOBEBiora Therapeutics Announces Closing of $6 Million..
01/04/202421:00GLOBEBiora Therapeutics Announces $6 Million Registered Direct..
27/03/202405:05GLOBEBiora Therapeutics Provides Corporate Update and Reports..
26/03/202420:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
18/03/202421:00GLOBEBiora Therapeutics to Report Fourth Quarter and Full Year..
11/03/202421:11EDGAR2Form 8-K - Current report
11/03/202421:00GLOBEBiora Therapeutics Further Reduces Net Debt and Monetizes..
26/02/202422:00GLOBEBiora Therapeutics Announces Successful Completion of..
16/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202404:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202422:00GLOBEBiora Therapeutics Announces Participation in Canaccord..
22/01/202422:00GLOBEBiora Therapeutics Announces Participation in Fireside Chat..
17/01/202407:20EDGAR2Form 8-K - Current report
16/01/202422:00GLOBEBiora Therapeutics Provides Outlook for 2024
08/01/202422:00GLOBEBiora Therapeutics Announces Initiation of Phase 1 Clinical..
02/01/202422:00GLOBEBiora Therapeutics Progresses Research Collaboration for the..
02/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
23/12/202307:19EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202306:35EDGAR2Form SC 13D/A - General statement of acquisition of..
19/12/202322:00GLOBEBiora Therapeutics Announces New Patent for its NaviCap™..
18/12/202322:06EDGAR2Form 8-K - Current report
18/12/202322:00GLOBEBiora Therapeutics Accelerates Debt Reduction and Raises..
16/12/202307:25EDGAR2Form 8-K - Current report
11/12/202322:00GLOBEBiora Therapeutics Announces New Research Collaboration for..
01/12/202320:06EDGAR2Form 8-K - Current report
01/12/202308:53DJNBiora Therapeutics Shares Rise 64% After FDA Clears..
01/12/202307:29DJNBiora Therapeutics Application for Ulcerative Colitis..
01/12/202306:48GLOBEBiora Therapeutics Announces FDA Clearance of IND..
14/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:05GLOBEBiora Therapeutics Provides Corporate Update and Reports ..
06/11/202322:00GLOBEBiora Therapeutics to Report Third Quarter 2023 Financial..
31/10/202305:05GLOBEBiora Therapeutics Submits Updated IND Application for..
24/10/202306:30GLOBEBiora Therapeutics to Submit Updated IND Application for..
13/10/202319:04EDGAR2Form 8-K - Current report
11/10/202319:01EDGAR2Form 8-K - Current report
07/10/202306:19EDGAR2Form 8-K - Current report
05/10/202321:00GLOBEBiora Therapeutics Presents Data on the BioJet™ Systemic..
25/09/202321:00GLOBEBiora Therapeutics Announces Submission of IND Application..
20/09/202305:15EDGAR2Form SC 13D/A - General statement of acquisition of..
19/09/202321:06EDGAR2Form 8-K - Current report
19/09/202321:00GLOBEBiora Therapeutics Reduces Debt and Largest Shareholder..
11/09/202321:01GLOBEBiora Therapeutics to Present at H.C. Wainwright 25th Annual..
05/09/202321:00GLOBEBiora Therapeutics Progresses its BioJet™ Systemic Oral..